Neuronal activity regulates extracellular tau in vivo

Journal of Experimental Medicine

Volumn 211, Issue 3, 2014, Pages 387-393

  Yamada, Kaoru ^a   Holth, Jerrah K ^a   Liao, Fan ^a   Stewart, Floy R ^a   Mahan, Thomas E ^a   Jiang, Hong ^a   Cirrito, John R ^a   Patel, Tirth K ^a   Hochgräfe, Katja ^b,c   Mandelkow, Eva Maria ^b,c   Holtzman, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; CELL PROTEIN; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; PICROTOXIN; PILOCARPINE; TAU PROTEIN; TETRODOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLEARANCE; CONTROLLED STUDY; DEPOLARIZATION; ELECTRIC POTENTIAL; ELECTROENCEPHALOGRAM; EXTRACELLULAR SPACE; HALF LIFE TIME; HIPPOCAMPUS; IN VIVO STUDY; INTERSTITIAL FLUID; MICRODIALYSIS; MICROTUBULE; MOUSE; NERVE CELL; NERVE CELL NETWORK; NERVE DEGENERATION; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN SECRETION; STEADY STATE; SYNAPTIC TRANSMISSION; TAUOPATHY; TURNOVER TIME;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; ELECTROENCEPHALOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; FEMALE; GLUTAMIC ACID; HALF-LIFE; KINETICS; LUCIFERASES; MALE; MICE; MICE, TRANSGENIC; MICRODIALYSIS; NEURONS; SYNAPTIC TRANSMISSION; TAU PROTEINS; TAUOPATHIES; TETRODOTOXIN;

EID: 84896830709     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131685     Document Type: Article

References (29)

1. Arriagada, P.V., J.H. Growdon, E.T. Hedley-Whyte, and B.T. Hyman. 1992. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:631-639. http://dx.doi.org/10.1212/WNL.42.3.631
2. Bancher, C., H. Braak, P. Fischer, and K.A. Jellinger. 1993. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci. Lett. 162:179-182. http://dx.doi.org/10.1016/0304-3940(93)90590-H
3. Bero, A.W., P. Yan, J.H. Roh, J.R. Cirrito, F.R. Stewart, M.E. Raichle, J.-M. Lee, and D.M. Holtzman. 2011. Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat. Neurosci. 14:750-756. http://dx.doi.org/10.1038/nn.2801
4. Braak, H., and E. Braak. 1995. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging. 16:271-278. http://dx.doi.org/10.1016/0197-4580(95)00021-6
5. Castellano, J.M., J. Kim, F.R. Stewart, H. Jiang, R.B. DeMattos, B.W. Patterson, A.M. Fagan, J.C. Morris, K.G. Mawuenyega, C. Cruchaga, et al. 2011. Human apoE isoforms differentially regulate brain amyloid- β peptide clearance. Sci. Transl. Med. 3:89ra57.
6. Chai, X., J.L. Dage, and M. Citron. 2012. Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol. Dis. 48:356-366. http://dx.doi.org/10.1016/j.nbd.2012.05.021
7. Cirrito, J.R., K.A. Yamada, M.B. Finn, R.S. Sloviter, K.R. Bales, P.C. May, D.D. Schoepp, S.M. Paul, S. Mennerick, and D.M. Holtzman. 2005. Synaptic activity regulates interstitial fluid amyloid-β levels in vivo. Neuron. 48:913-922. http://dx.doi.org/10.1016/j.neuron.2005.10.028
8. Cirrito, J.R., J.-E. Kang, J. Lee, F.R. Stewart, D.K. Verges, L.M. Silverio, G. Bu, S. Mennerick, and D.M. Holtzman. 2008. Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo. Neuron. 58:42-51. http://dx.doi.org/10.1016/j.neuron.2008.02.003
9. Clavaguera, F., T. Bolmont, R.A. Crowther, D. Abramowski, S. Frank, A. Probst, G. Fraser, A.K. Stalder, M. Beibel, M. Staufenbiel, et al. 2009. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11:909-913. http://dx.doi.org/10.1038/ncb1901
10. de Calignon, A., M. Polydoro, M. Suárez-Calvet, C. William, D.H. Adamowicz, K.J. Kopeikina, R. Pitstick, N. Sahara, K.H. Ashe, G.A. Carlson, et al. 2012. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron. 73:685-697. http://dx.doi.org/10.1016/j.neuron.2011.11.033
11. Eckermann, K., M.-M. Mocanu, I. Khlistunova, J. Biernat, A. Nissen, A. Hofmann, K. Schönig, H. Bujard, A. Haemisch, E. Mandelkow, et al. 2007. The β-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J. Biol. Chem. 282:31755- 31765. http://dx.doi.org/10.1074/jbc.M705282200
12. Frost, B., R.L. Jacks, and M.I. Diamond. 2009. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284:12845- 12852. http://dx.doi.org/10.1074/jbc.M808759200
13. Guo, J.L., and V.M.-Y. Lee. 2011. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J. Biol. Chem. 286:15317-15331. http://dx.doi.org/10.1074/jbc.M110.209296
14. Harris, J.A., A. Koyama, S. Maeda, K. Ho, N. Devidze, D.B. Dubal, G.-Q. Yu, E. Masliah, and L. Mucke. 2012. Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits. PLoS ONE. 7:e45881. http://dx.doi.org/10.1371/journal.pone.0045881
15. Hochgräfe, K., and E.-M. Mandelkow. 2013. Making the brain glow: in vivo bioluminescence imaging to study neurodegeneration. Mol. Neurobiol. 47:868-882. http://dx.doi.org/10.1007/s12035-012-8379-1
16. Iba, M., J.L. Guo, J.D. McBride, B. Zhang, J.Q. Trojanowski, and V.M.-Y. Lee. 2013. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J. Neurosci. 33:1024-1037. http://dx.doi.org/10.1523/JNEUROSCI.2642-12.2013
17. Jack, C.R. Jr., D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, P.S. Aisen, L.M. Shaw, P. Vemuri, H.J. Wiste, S.D. Weigand, et al. 2013. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12:207-216. http://dx.doi.org/10.1016/S1474-4422(12)70291-0
18. Karch, C.M., A.T. Jeng, and A.M. Goate. 2012. Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies. J. Biol. Chem. 287:42751-42762. http://dx.doi.org/10.1074/jbc.M112.380642
19. Kfoury, N., B.B. Holmes, H. Jiang, D.M. Holtzman, and M.I. Diamond. 2012. Trans-cellular propagation of Tau aggregation by fibrillar species. J. Biol. Chem. 287:19440-19451. http://dx.doi.org/10.1074/jbc.M112.346072
20. Lee, H.-J., S. Patel, and S.-J. Lee. 2005. Intravesicular localization and exocytosis of β-synuclein and its aggregates. J. Neurosci. 25:6016-6024. http://dx.doi.org/10.1523/JNEUROSCI.0692-05.2005
21. Liu, L., V. Drouet, J.W. Wu, M.P. Witter, S.A. Small, C. Clelland, and K. Duff. 2012. Trans-synaptic spread of tau pathology in vivo. PLoS ONE. 7:e31302. http://dx.doi.org/10.1371/journal.pone.0031302
22. Luk, K.C., V. Kehm, J. Carroll, B. Zhang, P. O'Brien, J.Q. Trojanowski, and V.M.-Y. Lee. 2012. Pathological β-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 338:949-953. http://dx.doi.org/10.1126/science.1227157
23. Maia, L.F., S.A. Kaeser, J. Reichwald, M. Hruscha, P. Martus, M. Staufenbiel, and M. Jucker. 2013. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein. Sci. Transl. Med. 5:re2.
24. Mohamed, N.-V., T. Herrou, V. Plouffe, N. Piperno, and N. Leclerc. 2013. Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission. Eur. J. Neurosci. 37:1939-1948. http://dx.doi.org/10.1111/ejn.12229
25. Pooler, A.M., E.C. Phillips, D.H.W. Lau, W. Noble, and D.P. Hanger. 2013. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. 14:389-394. http://dx.doi.org/10.1038/embor.2013.15
26. Price, J.C., S. Guan, A. Burlingame, S.B. Prusiner, and S. Ghaemmaghami. 2010. Analysis of proteome dynamics in the mouse brain. Proc. Natl. Acad. Sci. USA. 107:14508-14513. http://dx.doi.org/10.1073/pnas.1006551107
27. Van der Jeugd, A., K. Hochgräfe, T. Ahmed, J.M. Decker, A. Sydow, A. Hofmann, D. Wu, L. Messing, D. Balschun, R. D'Hooge, and E.-M. Mandelkow. 2012. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathol. 123:787-805. http://dx.doi.org/10.1007/s00401-012-0987-3
28. Verges, D.K., J.L. Restivo, W.D. Goebel, D.M. Holtzman, and J.R. Cirrito. 2011. Opposing synaptic regulation of amyloid-β metabolism by NMDA receptors in vivo. J. Neurosci. 31:11328-11337. http://dx.doi.org/10.1523/JNEUROSCI.0607-11.2011
29. Yamada, K., J.R. Cirrito, F.R. Stewart, H. Jiang, M.B. Finn, B.B. Holmes, L.I. Binder, E.-M. Mandelkow, M.I. Diamond, V.M.-Y. Lee, and D.M. Holtzman. 2011. In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J. Neurosci. 31:13110-13117. http://dx.doi.org/10.1523/JNEUROSCI.2569-11.2011